Awards & Advancement

Certara appoints Nathan Teuscher to lead Phoenix Software Division

Thursday, July 21, 2016

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced the appointment of Nathan Teuscher, Ph.D., to vice president of pharmacometric solutions. In his new role, Dr. Teuscher will lead the company’s Phoenix software division. He previously served as Certara’s vice president of scientific training.

[Read More]

CEO George Scangos to leave Biogen

Thursday, July 21, 2016

Biogen has announced that George Scangos, its chief executive officer, will be leaving the company in the coming months after a successor has been identified. The company will begin a search for his successor immediately.

[Read More]

Novella hires three new executives

Thursday, July 21, 2016

Three new team members have joined Novella Clinical. Fiona Markwood is Novella’s new executive vice president of Oncology Project Management; Anusha Bala, BSc, LLB, is Novella’s new global head of Regulatory Affairs; and Joy Yucaitis joins Novella as senior director of Oncology Strategy.

[Read More]

Exco InTouch successful completes HIPAA Privacy audit for NIST guidelines

Wednesday, July 20, 2016

Exco InTouch, a provider of patient engagement and data capture solutions for clinical research and healthcare providers, has announced that it has successfully undergone and completed an independent audit to assess compliance utilizing the National Institute of Standards and Technology (NIST) guidelines for Health Insurance Portability and Accountability Act (HIPAA), formally completing the independent auditing process for Privacy & Security.

[Read More]

Dr. Andreas Rummelt joins supervisory board of Leukocare

Tuesday, July 19, 2016

Leukocare, a provider of stabilizing and protecting formulation technologies for biopharmaceuticals like biologics and vaccines, announced the election of Dr. Andreas Rummelt as new member of its supervisory board. Together with Dr. Jean-Paul Prieels, who held various executive positions at GlaxoSmithKline, former Sandoz CEO Dr. Rummelt is the second former executive from big pharma on the Leukocare board. 

[Read More]